Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c

Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Aptevo raises $4.5M through warrant exercise and private placement
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15